...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Message: $1.70 close on light volume....

20,600 on the main TSX is what I'm seeing, plus a few thousand more on the secondaries.

New Message
Please login to post a reply